| Date | Detail |
|---|---|
| Dec 16, 2019 |
BeiGene Update Call: ASPEN Trial Readout
|
| Dec 03, 2019 |
BeiGene, Ltd. at the 31st Annual Piper Jaffray Healthcare Conference
|
| Oct 31, 2019 |
BeiGene Corporate Update: Global Strategic Oncology Collaboration with Amgen
|
| Sep 10, 2019 |
Morgan Stanley 17th Annual Global Healthcare Conference
|
| Sep 08, 2019 |
BeiGene Corporate Update Conference Call
|
| Jun 20, 2019 |
BeiGene Clinical Data Update Mid-2019
|
| Jun 12, 2019 |
BeiGene, Ltd. at the Goldman Sachs 40th Annual Global Healthcare Conference
|
| Mar 13, 2019 |
BeiGene, Ltd. at the Barclay’s Global Healthcare Conference
|
| Mar 11, 2019 |
BeiGene, Ltd. at the Cowen and Company 39th Annual Health Care Conference
|
| Mar 01, 2019 |
BeiGene, Ltd. at the 8th Annual SVB Leerink Global Healthcare Conference
|
| Feb 28, 2019 |
Hong Kong Investor Event
|
| Feb 27, 2019 |
Q4 2018 BeiGene, Ltd. Earnings Conference Call
|
| Feb 14, 2019 |
Guggenheim Healthcare Talks Idea Forum | Oncology Day
|
| Dec 03, 2018 |
BeiGene Analyst and Investor Event
|
| Nov 28, 2018 |
BeiGene, Ltd. at the 30th Annual Piper Jaffray Healthcare Conference
|
| Oct 12, 2018 |
IWWM Oral Presentation on Zanubrutinib
|
| Oct 03, 2018 |
BeiGene, Ltd. at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
|
| Oct 02, 2018 |
BeiGene, Ltd. at the Ladenburg Thalmann 2018 Healthcare Conference
|
| Sep 12, 2018 |
BeiGene, Ltd. at the Morgan Stanley 16th Annual Global Healthcare Conference
|
| Jun 15, 2018 |
BeiGene, Ltd. at the 23rd Congress of the European Hematology Association (EHA)
|
